CNS Pharmaceuticals CNSP
NASDAQ CNSP
$5.24 -0.23 (-4.20%)
As of: Oct 1, 2026 · 1:41 PM EDT

CNS Pharmaceuticals (CNSP) Liabilities and Shareholders Equity (2018 - 2025)

Updated

CNS Pharmaceuticals (CNSP) posted Liabilities and Shareholders Equity of $8.62 million for Q4 2025, down 0.9% from $8.7 million a year earlier and down 27.3% from the prior quarter.

Analysis

CNS Pharmaceuticals (CNSP) Liabilities and Shareholders Equity (2018 - 2025) Analysis & Trends

Since Q4 2018, CNS Pharmaceuticals has reported Liabilities and Shareholders Equity for 27 quarters.

  • Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -11.5% (FY2020 to FY2025).
  • In prior years, CNS Pharmaceuticals' Liabilities and Shareholders Equity was $8.7 million in FY2024 (+411.6%), $1.7 million in FY2023 (-87.0%), $13.05 million in FY2022 (+49.1%) and $8.76 million in FY2021 (-44.8%).
  • The Q4 2025 figure stands as the lowest quarterly Liabilities and Shareholders Equity since Q3 2024.
  • On a year-over-year basis, Liabilities and Shareholders Equity increased in five of the last eight quarters, with growth averaging 220.6%.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q1 2025, with growth of 727.8%; the weakest was Q4 2023, with a decline of 87.0%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $11.87 million (Q3 2025), $14.51 million (Q2 2025) and $13.75 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 CNS Pharmaceuticals 2.35 Mn -39.89 Mn - 8.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 8.62 Mn
Sep 30, 2025 11.87 Mn
Jun 30, 2025 14.51 Mn
Mar 31, 2025 13.75 Mn
Dec 31, 2024 8.70 Mn
Sep 30, 2024 7.41 Mn
Jun 30, 2024 2.47 Mn
Mar 31, 2024 1.66 Mn
Dec 31, 2023 1.70 Mn
Sep 30, 2023 2.33 Mn
Jun 30, 2023 6.45 Mn
Mar 31, 2023 7.41 Mn
Dec 31, 2022 13.05 Mn
Sep 30, 2022 9.64 Mn
Jun 30, 2022 12.45 Mn
Mar 31, 2022 15.87 Mn
Dec 31, 2021 8.76 Mn
Sep 30, 2021 11.51 Mn
Jun 30, 2021 14.24 Mn
Mar 31, 2021 13.14 Mn
API Access

CNS Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CNSP&period=max&api_key=YOUR_API_KEY